Reverse Proteomics Research Institute Co., Ltd.
Records under this name other than patents Reverse Proteomics Research Institute Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Reverse Proteomics Research Institute Co., Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,778,613 | Affinity Resin Formerly held In force · High confidence | In force | High confidence | |
| US 7,456,022 | Solid support having ligand immobilized thereon by using photocleavable linker Formerly held Term ended Term ended Jul 28, 2025 · USPTO record | Term ended | Term ended Jul 28, 2025 | USPTO record |
| US 7,919,653 | Method of Inhibiting Nonspecific Interaction Between Molecules on Solid Phase Support Formerly held Lapsed on the fee record Ended Apr 5, 2023 · High confidence | Lapsed on the fee record | Ended Apr 5, 2023 | High confidence |
| US 7,923,211 | Method of calibrating ligand specificity Formerly held Lapsed on the fee record Ended Apr 12, 2019 · USPTO record | Lapsed on the fee record | Ended Apr 12, 2019 | USPTO record |
| US 7,645,614 | Method of Immobilizing Compound on Solid Phase Support Formerly held Lapsed on the fee record Ended Jan 12, 2018 · High confidence | Lapsed on the fee record | Ended Jan 12, 2018 | High confidence |
| US 7,592,187 | Method of calibrating ligand specificity Formerly held Lapsed on the fee record Ended Sep 22, 2017 · USPTO record | Lapsed on the fee record | Ended Sep 22, 2017 | USPTO record |
| US 8,309,687 | Biomarker specific for cancer Lapsed on the fee record Ended Nov 13, 2016 · USPTO record | Lapsed on the fee record | Ended Nov 13, 2016 | USPTO record |
| US 8,178,077 | Drug Development Target Protein and Target Gene, and Method of Screening Lapsed on the fee record Ended May 15, 2016 · High confidence | Lapsed on the fee record | Ended May 15, 2016 | High confidence |
| US 8,153,385 | Target protein and target gene in drug designing and screening method Lapsed on the fee record Ended Apr 10, 2016 · USPTO record | Lapsed on the fee record | Ended Apr 10, 2016 | USPTO record |
| US 8,153,764 | Biomarker Specific to Brain/Nerve or Specific to Neuronal Differentiation Lapsed on the fee record Ended Apr 10, 2016 · High confidence | Lapsed on the fee record | Ended Apr 10, 2016 | High confidence |